ANTISYNTHETASE SYNDROME
Clinical trials for ANTISYNTHETASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTISYNTHETASE SYNDROME trials appear
Sign up with your email to follow new studies for ANTISYNTHETASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at autoimmune diseases
Disease control Not yet recruitingThis early study tests a new treatment called CD19/BCMA CAR-T for people with severe autoimmune diseases like lupus and Sjögren's syndrome that haven't improved with standard care. The treatment involves taking a patient's own immune cells, modifying them to target specific immun…
Matched conditions: ANTISYNTHETASE SYNDROME
Phase: NA • Sponsor: Shenzhen Genocury Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study aims to predict best treatments for rheumatoid diseases using AI and health data
Knowledge-focused Not yet recruitingThis study will collect health information, samples, and data from 100 people in Luxembourg (800 total across Europe) who have rheumatoid diseases and are starting or changing treatment. Researchers hope to find patterns that can predict which treatments work best for each person…
Matched conditions: ANTISYNTHETASE SYNDROME
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:31 UTC